XML 21 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities      
Net loss $ (119,491,000) $ (79,049,000) $ (57,221,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation expense 23,100,000 16,784,000 10,251,000
Amortization of investment premiums and discounts 732,000 2,582,000 3,465,000
Depreciation and amortization expense 956,000 383,000 48,000
Loss on foreign exchange 0 0 94,000
Write-off of property and equipment 0 0 21,000
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (784,000) (742,000) (767,000)
Other assets 2,000 6,000 (61,000)
Accounts payable 2,163,000 981,000 1,005,000
Accrued compensation 1,919,000 1,121,000 1,399,000
Accrued research and development expenses 1,598,000 (2,704,000) 4,288,000
Other current liabilities 1,896,000 215,000 293,000
Long-term liabilities 407,000 398,000 29,000
Net cash used in operating activities (87,502,000) (60,025,000) (37,156,000)
Investing activities      
Purchases of short-term investments (176,459,000) (304,928,000) (379,776,000)
Sales of short-term investments 107,627,000 242,643,000 64,020,000
Maturities of short-term investments 188,973,000 149,046,000 96,113,000
Purchases of property and equipment (20,232,000) (3,020,000) (290,000)
Restricted cash (1,200,000) 0 (194,000)
Net cash provided by (used in) investing activities 98,709,000 83,741,000 (220,127,000)
Financing activities      
Taxes paid related to net share settlement of restricted stock units (357,000) (94,000) (4,647,000)
Proceeds from employee stock awards 1,249,000 600,000 439,000
Net cash provided by financing activities 20,048,000 506,000 259,226,000
Effect of exchange rates on cash 0 0 (94,000)
Increase in cash and cash equivalents 31,255,000 24,222,000 1,849,000
Cash and cash equivalents at beginning of period 47,968,000 23,746,000 21,897,000
Cash and cash equivalents at end of period 79,223,000 47,968,000 23,746,000
Non-cash investing and financing activities      
Property and equipment purchases included in accounts payable and other accrued liabilities 10,122,000 352,000 0
Capitalized lease obligations 9,904,000 0 0
Property & equipment acquired under capital leases 1,076,000 0 0
Asset retirement cost 580,000 0 0
Interest capitalized during construction period for build-to-suit lease transaction 264,000 0 0
Proceeds from options exercised not yet received 439,000 0 0
Accrued costs related to underwritten public offering 160,000 0 0
Issuance of common stock upon vesting of stock awards 0 60,000 80,000
Change in long-term liabilities related to non-vested stock awards 0 (60,000) (80,000)
Supplemental cash flow disclosure      
Cash paid for taxes 0 10,000 3,000
Underwritten Offerings      
Financing activities      
Proceeds from sale of common stock, net 0 0 263,434,000
At The Market Offering      
Financing activities      
Proceeds from sale of common stock, net $ 19,156,000 $ 0 $ 0